Dr. Kurt Jaeckle to Lead Phase III Clinical Trial of Novel Drug VAL-083 for Late-Stage Glioblastoma
Atlantic Health System's Gerald J. Glasser Brain Tumor Center, one of four study sites in the country, opens Phase III study of first-in-class cancer drug. SUMMIT, NJ, USA, January 13, 2018 /EINPresswire.com/ -- The Gerald J. Glasser Brain Tumor …